RAD 2025: Renowned AD investigator Kircik provides the history behind the classwide black box warning, highlights JAK inhibitor efficacy, and toplines exciting AD research.
Leon Kircik, MD
Advertisement
Articles by Leon Kircik, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears Wave Neuroscience MeRT System for PTSD
2
Zasocitinib Tops Deucravacitinib for Skin Clearance in Phase 3 Psoriasis Trial
3
AD109 Reduces OSA Severity in Phase 3 Trial of CPAP-Intolerant Adults
4
7 Late-Breaking Clinical Trials to Watch For at SLEEP 2026
5